Indo Us Biotech Limited
Indo Us Biotech Limited (INDOUS): company summary
The company's revenue grew 6.2% annually, but net profit fell 18.0% year-on-year.
Indo Us Biotech Limited (INDOUS) is a micro-cap Fast Moving Consumer Goods company valued at ₹147 crore operating in Other Agricultural Products on the NSE and BSE.
- Recent price move
- Indo Us Biotech Limited last traded at ₹71.99, modestly up 0.49% on the day.
- Recent developments
- On 2026-09-16, the company released a preview for its Q2 FY27 results, highlighting concerns about margins.
- Financial performance
- The company's revenue grew 6.2% annually, but net profit fell 18.0% year-on-year. In the latest quarter, revenue rose 7.2% compared to the same quarter a year earlier, but net profit dropped 35.3%, indicating margin pressure.
- Valuation multiples
- The stock trades at 11.0 times earnings, a discount to the Fast Moving Consumer Goods median of 19.6, 1.68 times book value. It yields 0.3%.
- Things to watch
- Net profit margin narrowed 3.5 percentage points to 11.9%, and the latest quarter's net profit fell 35.3% compared to the same quarter a year earlier. The stock is 51.7% below its 52-week high.
- Where it stands
- Indous has seen strong revenue growth over the past five years, but profit growth has slowed, with net profit falling 18.0% annually. The latest quarter's net profit dropped 35.3% compared to the same quarter a year earlier, raising concerns about margin pressure.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (9.0) and valuation (7.6), but held back by momentum (0.0). Growth looks strong at 9.0, but that is offset by momentum at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Profitable in all of the last 5 years
- Undemanding at 11× earnings
- Revenue compounding 23% a year
- Momentum is weak (0.0/10)
- Near the bottom of its 52-week range (2%)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Fast Moving Consumer Goods stocks · Other Agricultural Products
Explore Indo Us Biotech Limited’s valuation
Free deep-dive tools · no sign-up
Indo Us Biotech Limited peers in Fast Moving Consumer Goods
Other Fast Moving Consumer Goods stocks on the NSE & BSE. See the full Fast Moving Consumer Goods sector list.
Compare Indo Us Biotech Limited with peers
Related tools & concepts
Value Indo Us Biotech Limited with the ratios and calculators DocStoX uses in its analysis.

